About Lifecore
Lifecore is a company based in Chaska (United States) founded in 1965 was acquired by Landec in April 2010.. The company has 406 employees as of May 31, 2024. Lifecore offers products and services including Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate. Lifecore operates in a competitive market with competitors including Bloomage Biotechnology, Fidia Farma, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others.
- Headquarter Chaska, United States
- Employees 406 as on 31 May, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lifecore Biomedical, Inc.
-
Annual Revenue
$128.87 M0.47as on May 31, 2025
-
Net Profit
$-38.72 M-422.29as on May 31, 2025
-
EBITDA
$-3.98 M-590.02as on May 31, 2025
-
Latest Funding Round
$24.3 M (USD), Post-IPO
Oct 04, 2024
-
Investors
Wynnefield Capital
& 1 more
-
Employee Count
406
as on May 31, 2024
-
Acquired by
Landec
(Apr 30, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lifecore
Lifecore is a publicly listed company on the NASDAQ with ticker symbol LFCR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lifecore
Lifecore offers a comprehensive portfolio of products and services, including Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services for scaling drug products from concept to commercial supply.
Production and packaging of injectable medical devices and pharmaceuticals.
On-site labs for sample analysis and stability testing.
Non-animal-sourced hyaluronate for research and commercial applications.
Unlock access to complete
Funding Insights of Lifecore
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $24.3M
-
First Round
First Round
(05 Dec 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Post-IPO - Lifecore | Valuation |
investors |
|
| Nov, 2022 | Amount | Post-IPO - Lifecore | Valuation |
investors |
|
| Oct, 2019 | Amount | Debt – Conventional - Lifecore | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lifecore
Lifecore has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Wynnefield Capital and Landec. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manages investment funds for sophisticated financial investors worldwide.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lifecore
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lifecore
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lifecore Comparisons
Competitors of Lifecore
Lifecore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bloomage Biotechnology, Fidia Farma, Contipro, Qingdao Kangyuan Pharmaceutica and Altergon Italia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of hyaluronic acid & pharmaceutical products
|
|
| domain | founded_year | HQ Location |
Proprietary hyaluronic acid treatments and derivatives are developed.
|
|
| domain | founded_year | HQ Location |
Manufacturer of hyaluronic acid-based products
|
|
| domain | founded_year | HQ Location |
Operates as a CDMO specializing in hyaluronidase manufacturing.
|
|
| domain | founded_year | HQ Location |
Develops and manufactures pharmaceutical products and medical devices for clients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lifecore
Frequently Asked Questions about Lifecore
When was Lifecore founded?
Lifecore was founded in 1965 and raised its 1st funding round 53 years after it was founded.
Where is Lifecore located?
Lifecore is headquartered in Chaska, United States. It is registered at Chaska, Minnesota, United States.
How many employees does Lifecore have?
As of May 31, 2024, the latest employee count at Lifecore is 406.
What is the annual revenue of Lifecore?
Annual revenue of Lifecore is $128.87M as on May 31, 2025.
What does Lifecore do?
Lifecore Biomedical, a wholly owned subsidiary of Landec Corporation (Nasdaq: LNDC), is dedicated to the development of technically advanced hyaluronan-based products that offer long-term compatibility with the human body. Since 1986, more than 50 million patients worldwide have benefited from Lifecores innovations in sodium hyaluronate products. The companys products meet or exceed the highest standards set by the United States Food and Drug Administration, the European Community and other international agencies. The Lifecore facility is ISO 13485 and GMP certified, international symbols of quality system assurance and compliance.
Who are the top competitors of Lifecore?
Lifecore's top competitors include Bloomage Biotechnology, Fidia Farma and Contipro.
What products or services does Lifecore offer?
Lifecore offers Process Development, Clinical Manufacturing, Analytical Services, and Sodium Hyaluronate.
Is Lifecore publicly traded?
Yes, Lifecore is publicly traded on NASDAQ under the ticker symbol LFCR.
Who are Lifecore's investors?
Lifecore has 2 investors. Key investors include Wynnefield Capital, and Landec.
What is Lifecore's ticker symbol?
The ticker symbol of Lifecore is LFCR on NASDAQ.